https://www.selleckchem.com/products/pf-04929113.html Results Comparing dabigatran to warfarin, estimated 2-year RDs for ischemic stroke were similar with trial transport and non-experimental methods. However, 2-year mortality RDs were closer to the null when using trial transport versus non-experimental methods for the dabigatran target population (transported RD -0.57%; non-experimental RD -1.9%). Estimated gastrointestinal bleeding RDs from trial transport (dabigatran initiator RD 1.8%; warfarin initiator RD 1.9%) appeared more harmful than non-experimental results (dabigatran initiator RD 0.14%; warfarin initiator RD 0.57%). Conclusions Differences in study populations can and should be considered quantitatively to ensure results are relevant to populations of interest, particularly when comparing trial with non-experimental findings.Objective To evaluate the safety and efficacy of a new topical skin ointment with natural ingredients (aloe vera, honey, and peppermint) for dressing skin graft donor sites. Design A double-blind, placebo-controlled, randomized clinical trial. Patients and intervention Researchers enrolled patients who were referred for split-thickness skin graft after burns or surgical wounds on the scalp or face area. For each patient, a thin layer of skin (depth, 0.04 mm; approximate size, less than 15 × 7 cm) was harvested from the thigh by a plastic surgeon with an electric or manual dermatome. The donor sites were divided and randomized to receive either natural ointment or petroleum jelly as a topical agent to dressing. Topical agents were applied on donor site wounds on days 0, 4, 7, and 14. Main outcome measures Wound size, pain, erythema, pruritus, patient discomfort, complications, and physician satisfaction were evaluated at each visit. Main results Among 28 patients, there was no significant difference between the two treatment agents regarding the rate of wound healing (P = .415), pain (P = .081), pruritus (P = .527), and patient disco